Could Gene Therapy Become The ‘Ozempic’ For Bad Cholesterol? 6 Things To Know About Eli Lilly’s Breakthrough Research

Eli Lilly and Verve Therapeutics’ experimental gene-editing therapy VERVE-102 is showing promising results in lowering bad cholesterol with a single dose.